Clinical Trial Update: Safety and Efficacy of Eltrombopag Plus Pulsed Dexamethasone for Subjects With Idiopathic Thrombocytopenic Purpura [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating eltrombopag with pulsed dexamethasone for immune thrombocytopenia (idiopathic thrombocytopenic purpura) has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Idiopathic Thrombocytopenic Purpura
• Immune Thrombocytopenia

Drugs mentioned

• Eltrombopag (eltrombopag)
• Pulsed Dexamethasone (dexamethasone)

Snippet

Sponsor: Humanity & Health Medical Group Limited | Conditions: Immune Thrombocytopenia | Phase 2 | Status: COMPLETED